摘要
目的:观察莫西沙星治疗老年急性肺炎患者的临床治疗效果。方法:将66例患者随机分成两组,应用莫西沙星治疗为治疗组,应用左氧氟沙星治疗为对照组。结果:治疗组治疗有效率、细菌清除率、不良反应发生率分别为90.91%、93.94%、9.09%,对照组治疗有效率、细菌清除率、不良反应发生率分别为78.79%、81.82%、12.12%,两组治疗有效率、细菌清除率分别比较,差异均有统计学意义(P<0.05),而不良反应发生率比较,差异无统计学意义(P>0.05)。结论:莫西沙星是一种治疗老年急性肺炎安全、有效的药物。
Objective：To observe the clinical effect of Moxifloxacin in treatment of elderly patients with acute pneumonia.Methods：66 patients were randomly divided into 2 groups,33 patients were treated with Moxifloxacin（treatment group） and 33 patients were treated with Levofloxacin（control group）.Results：The effective rate,bacterial clearing rate and occurrence of the adverse reaction for treatment group were 90.91%,93.94%,9.09% respectively and for control group were 78.79%,81.82%,12.12% respectively,the effective rate,bacterial clearing rate of two groups were compared,the differences were statistically significant（P〈0.05）,while the adverse reaction of two groups were compared,the difference was not significant（P〉0.05）.Conclusion：Moxifloxacin is a safe and effective medicine for treating elderly patients with acute pneumonia.
出处
《中国医药导报》
CAS
2010年第22期99-100,共2页
China Medical Herald
